LSA
GILD icon

Lansing Street Advisors’s Gilead Sciences GILD Stock Holding History

Lansing Street Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$320K Buy
4,153
+130
+3% +$10.4K 0.19% 62
2023
Q1 		$334K Buy
4,023
+35
+0.9% +$2.9K 0.21% 64
2022
Q4 		$342K Buy
+3,988
New +$316K 0.23% 61

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Lansing Street Advisors's GILD Position: Q2 2023 in Review

Lansing Street Advisors increased its Gilead Sciences (GILD) stake by 3.2% in Q2 2023, buying an estimated $10.4K and bringing the position to 4,153 shares worth $320K. The position accounts for 0.19% of the portfolio, ranked #62.

Lansing Street Advisors first reported a position in GILD in Q4 2022 and has held it in 3 quarters since. The position peaked at $342K in Q4 2022. 1,701 funds tracked by Wall St. Rank hold GILD as of Q2 2023.

  • Lansing Street Advisors held 4,153 shares of Gilead Sciences worth $320K as of Q2 2023.
  • Lansing Street Advisors bought 130 Gilead Sciences shares in Q2 2023, an estimated $10.4K.
  • Gilead Sciences made up 0.19% of Lansing Street Advisors's portfolio in Q2 2023, its #62 holding.
  • Lansing Street Advisors first reported a position in Gilead Sciences in Q4 2022 and has held it in 3 quarters since.
  • Lansing Street Advisors's Gilead Sciences position peaked at $342K in Q4 2022.
  • 1,701 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2023.

Based on Lansing Street Advisors's 13F filing for Q2 2023, filed 11 Aug 2023.